Friday 6 November 2026 Export ARQT’s income statement to Excel — free account

Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $376.1 million, up 91.3% from fiscal 2024.

Revenue: +45.1%
EPS: +12.0%
Free cash flow: +1,171.9%
Total debt: +0.83%

Quarter to September 2026, against a year earlier

25.55 1.45 −5.37%

Follow ARQT

Alert me

Market cap: $3.4B
P/E: 112×
Fwd P/E: 81.2×
Dividend yield: —
F-score: 4/9
Altman Z: 6.98
Beneish M: −1.52
Dividend safety: n/a

Overview

Arcutis Biotherapeutics, Inc. (ARQT) P/E ratio

Alert me on P/E ratio

As of 6 November 2026, Arcutis Biotherapeutics, Inc. (ARQT) trades at a P/E ratio of 112×. Over the past ten years it has ranged from 0.0× (June 2026) to 150× (November 2026); the current reading is higher than 96% of that period. That is above the Biotechnology industry median of 10.3× and above the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ARQT/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Arcutis Biotherapeutics, Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ARQT/metrics/pe-ratio">Arcutis Biotherapeutics, Inc. (ARQT) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	0.0×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	0.0×	—

Period	P/E ratio	Change
Sep 2026	116×	(2.39%)
Jun 2026	119×	—
Mar 2026	0.0×	—
Dec 2025	0.0×	—
13 more quarters	Free account

Against its own ten years

Low 0.0× High 150×

Ten-year median 0.0×

Current reading's percentile 96

Company	P/E ratio
LEGN Legend Biotech Corporation Sponsored ADR compare	n/m
DFTX Definium Therapeutics, Inc. compare	n/m
TNGX Tango Therapeutics, Inc. compare	n/m
EWTX Edgewise Therapeutics, Inc. compare	n/m
DNTH Dianthus Therapeutics, Inc. compare	n/m
ABCL AbCellera Biologics Inc. compare	n/m
IOVA Iovance Biotherapeutics, Inc. compare	n/m
RLAY Relay Therapeutics, Inc. compare	n/m
ARQT Arcutis Biotherapeutics, Inc.	119×
Biotechnology industry median	10.3×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Arcutis Biotherapeutics, Inc. (ARQT) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ARQT

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ARQT

Stockrow Weekly